Algoma Steel Group Inc (ASTL)
Toronto Exchange · Canada · prices in CAD · close of 19 Oct 2026
Key indicators
| Last close | CAD 5.830 |
|---|---|
| 52-week range | 4.460 – 8.160 |
| Return, 1 month / 3 months | −5.4% / +8.8% |
| Return, 1 year / 3 years | +6.6% / −32.0% |
| Trend | Below its 200-day average |
| RSI (14) | 46 |
| Volatility (1 year) | 67.4% |
| Worst drawdown (1 year) | -36.7% |
| Average daily value traded | 3.56M CAD |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Algoma Steel Group Inc is a Canadian steelmaker based in Sault Ste. Marie, Ontario. It produces flat-rolled steel products, including hot-rolled and cold-rolled sheet and plate, at its integrated steelworks. Its customers are spread across construction, automotive, manufacturing and energy markets, and the company also supplies steel for pipe and tube making. The business covers steelmaking from raw materials through finishing, and it ships its products mainly to customers in Canada and the United States.
The shares are listed on the Toronto Exchange in Canada under the code ASTL, and the price on this page is in Canadian dollars (CAD). Our dividend records, which start in 2019, show payments in 4 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Algoma Steel Group Inc (ASTL) trades on the Toronto Exchange in Canada. It last closed at CAD 5.830 on 19 October 2026.
Its price-based Market X-Ray is 45 out of 100 (a weak price profile), ranking 543 of 868 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 6.6% and over the last three months it rose 8.8%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Toronto Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 38 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -4.9% | ||
| From 52-week high | -27.4% | ||
| Momentum | 54 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 8.8% | ||
| 6-month return | -10.3% | ||
| 12-month return, skipping the last month | 12.6% | ||
| Stability (higher is calmer) | 31 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 67.4% | ||
| Worst drawdown, 1 year (smaller is calmer) | -36.7% | ||
| Liquidity | 67 · Fair | Moderate trading activity. | |
| Average daily value traded | 3.56M CAD | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 4 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | −5.2% |
|---|---|
| 1 month | −5.4% |
| 3 months | +8.8% |
| 6 months | −10.3% |
| 1 year | +6.6% |
| 3 years | −32.0% |
| 5 years | – |
Signals
| 50-day / 200-day average | 6.006 / 6.130 |
|---|---|
| Golden / death cross (60 days) | Death, 46 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.294 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 13 May 2025 | CAD 0.0700 |
| 21 Mar 2025 | CAD 0.0720 |
| 27 Nov 2024 | CAD 0.0700 |
| 23 Aug 2024 | CAD 0.0680 |
| 2 Jul 2024 | CAD 0.0690 |
| 28 Feb 2024 | CAD 0.0680 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Toronto Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.